マイコプラズマ検査の市場規模、シェア、成長分析：製品別、技術別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

マイコプラズマ検査の世界市場規模は、2023年に8億3,240万米ドルと評価され、2024年の8億9,733万米ドルから2032年には16億3,644万米ドルに成長し、予測期間（2025～2032年）のCAGRは7.8％で成長する見通しです。

マイコプラズマ検査市場は、製薬およびバイオテクノロジー分野での汚染問題の増加により、大きく成長する見込みです。研究イニシアチブの高まりとバイオ医薬品業界におけるマイコプラズマ検査キット需要の高まりが1次成長の起爆剤となっています。新興市場は、医療インフラの改善や、欧州医薬品庁（EMA）や米国食品医薬品局（FDA）のような、生物製剤やワクチンに対する厳格な検査を義務付ける機関による規制の強化によって、この動向に貢献すると予想されます。さらに、Minerva Biolabs GmbHの高感度VenorGeM Advanceアッセイに代表される技術革新は、検査の精度と効率を高めています。このような需要、規制当局の支援、技術革新の相乗的成長により、マイコプラズマ検査市場は今後数年間で大幅に拡大するものと思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術分析

マイコプラズマ検査市場規模：製品別

• 市場概要
• 機器
• キットと試薬
  • PCRアッセイ
  • 核酸検出キット
  • 汚れ
  • 除去キット
  • 標準と管理
  • その他
• サービス

マイコプラズマ検査市場規模：技術別

• 市場概要
• PCR
• ELISA
• 直接分析
• 間接分析
• 微生物培養技術
• 酵素法

マイコプラズマ検査市場規模：用途別

• 市場概要
• 細胞株検査
• ウイルス検査
• 生産終了セルの検査
• その他

マイコプラズマ検査市場規模：エンドユーザー別

• 市場概要
• 学術調査機関
• 細胞バンク
• 契約調査機関
• 製薬・バイオテクノロジー企業
• その他

マイコプラズマ検査市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（USA）
• Merck KGaA（Germany）
• Lonza Group Ltd.（Switzerland）
• Charles River Laboratories International Inc.（USA）
• Eurofins Scientific SE（Luxembourg）
• Roche Diagnostics（Switzerland）
• Agilent Technologies Inc.（USA）
• Bio-Rad Laboratories Inc.（USA）
• Sartorius AG（Germany）
• bioMerieux SA（France）
• Asahi Kasei Corporation（Japan）
• American Type Culture Collection（ATCC）（USA）
• Bionique Testing Laboratories Inc.（USA）
• InvivoGen（USA）
• PromoCell GmbH（Germany）
• Biological Industries Israel Beit Haemek Ltd.（Israel）
• Creative Bioarray（USA）
• Mycoplasma Experience（UK）
• Norgen Biotek Corp.（Canada）
• Biotools B & M Labs S.A.（Spain）

結論と提言

Global Mycoplasma Testing Market size was valued at USD 832.4 million in 2023 and is poised to grow from USD 897.33 million in 2024 to USD 1636.44 million by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The mycoplasma testing market is poised for significant growth, driven by increased contamination issues within the pharmaceutical and biotechnology sectors. Rising research initiatives and heightened demand for mycoplasma testing kits in biopharmaceutical industries are primary growth catalysts. Emerging markets are expected to contribute to this trend, bolstered by improved healthcare infrastructures and regulatory mandates from bodies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), which enforce stringent testing for biologics and vaccines. Moreover, technological innovations, exemplified by Minerva Biolabs GmbH's highly sensitive VenorGeM Advance assay, are enhancing testing accuracy and efficiency. This synergistic growth of demand, regulatory support, and innovation positions the mycoplasma testing market for substantial expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segments Analysis

Global Mycoplasma Testing Market is segmented by Product, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Kits & Reagents and Services. Based on Technology, the market is segmented into PCR, ELISA, Direct Assay, Indirect Assay, Microbial Culture Techniques and Enzymatic Methods. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End of Production Cells Testing and Others. Based on End-User, the market is segmented into Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mycoplasma Testing Market

The Global Mycoplasma Testing market is experiencing a significant surge in demand, primarily fueled by the growing research and development efforts in the biotechnology and pharmaceutical sectors, particularly concerning cell-based therapies and vaccines. As the reliance on cell lines for production intensifies, the necessity for contamination-free cell line streams has become critical. Moreover, as companies place a greater emphasis on quality assurance in their research processes, the demand for mycoplasma testing continues to escalate, alongside the need for more stringent and effective testing protocols. This trend highlights the crucial role of mycoplasma testing in ensuring product safety and efficacy in the industry.

Restraints in the Global Mycoplasma Testing Market

The Global Mycoplasma Testing market faces significant challenges due to a shortage of skilled personnel proficient in contemporary testing methodologies. Effective mycoplasma testing relies heavily on expert knowledge and proper implementation of testing procedures, and the scarcity of adequately trained professionals could impede progress in this field. This issue is particularly pronounced in developing countries, where resources for training and education are often limited, further obstructing the widespread adoption of mycoplasma testing solutions. The lack of expertise not only affects the implementation of existing techniques but also hinders innovations and improvements that could benefit the industry as a whole.

Market Trends of the Global Mycoplasma Testing Market

The Global Mycoplasma Testing market is experiencing a significant trend towards automation within laboratory operations, particularly in the biopharmaceutical sector. Automated systems streamline mycoplasma testing processes, drastically reducing testing times and enhancing productivity while minimizing human error. As biopharmaceutical companies increasingly emphasize process efficiency and consistency in quality, the demand for advanced mycoplasma testing technologies is projected to rise. This shift towards automation aligns with broader industry trends aimed at optimizing research and manufacturing practices, ultimately driving growth and innovation in the mycoplasma testing market as companies seek to ensure product safety and efficacy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Mycoplasma Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits & Reagents
  • PCR Assays
  • Nucleic Acid Detection Kits
  • Stains
  • Elimination Kits
  • Standards & Controls
  • Others
• Services

Global Mycoplasma Testing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• PCR
• ELISA
• Direct Assay
• Indirect Assay
• Microbial Culture Techniques
• Enzymatic Methods

Global Mycoplasma Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others

Global Mycoplasma Testing Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Others

Global Mycoplasma Testing Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Type Culture Collection (ATCC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionique Testing Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InvivoGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological Industries Israel Beit Haemek Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mycoplasma Experience (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotools B & M Labs S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations